Sabby Management 13F annual report
By Daniel Kim
Sabby Management is an investment fund managing more than $29.1 billion ran by Robert Grundstein. There are currently 68 companies in Mr. Grundstein’s portfolio. The largest investments include Brainstorm Cell Therapeutics and Biora Therapeutics Inc, together worth $4.47 billion.
Limited to 30 biggest holdings
$29.1 billion Assets Under Management (AUM)
As of 7th August 2023, Sabby Management’s top holding is 1,267,871 shares of Brainstorm Cell Therapeutics currently worth over $2.61 billion and making up 9.0% of the portfolio value.Relative to the number of outstanding shares of Brainstorm Cell Therapeutics, Sabby Management owns more than approximately 0.1% of the company.In addition, the fund holds 482,609 shares of Biora Therapeutics Inc worth $1.86 billion. The third-largest holding is Sonnet Biotherapeutics Hldng Inc worth $1.61 billion and the next is Akari Therapeutics Plc worth $1.26 billion, with 7,392,131 shares owned.
Currently, Sabby Management's portfolio is worth at least $29.1 billion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Sabby Management
The Sabby Management office and employees reside in Spicewood, Texas. According to the last 13-F report filed with the SEC, Robert Grundstein serves as the Chief Operating Officer at Sabby Management.
